Spontaneous apoptosis in gallbladder carcinoma: Relationships with clinicopathologic factors, expression of E-cadherin, bcl-2 protooncogene, and p53 oncosuppressor gene

Cancer

Volumn 78, Issue 10, 1996, Pages 2101-2110

  Sasatomi, Eizaburo ^a   Tokunaga, Osamu ^a   Miyazaki, Kohji ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

apoptosis; bcl 2; cell to cell contact; E cadherin; gallbladder carcinoma; p53

Indexed keywords

PROTEIN P53; UVOMORULIN;

APOPTOSIS; ARTICLE; CELL ADHESION; CELL DEATH; CELL INTERACTION; CELL LOSS; CYTOTOXICITY; GALLBLADDER CARCINOMA; GENE FREQUENCY; HISTOLOGY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTO ONCOGENE; TUMOR SUPPRESSOR GENE;

AGED; AGED, 80 AND OVER; APOPTOSIS; CADHERINS; FEMALE; GALLBLADDER NEOPLASMS; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0029998561     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19961115)78:10<2101::AID-CNCR10>3.0.CO;2-2     Document Type: Article

References (48)

1. Henson DE, Albores-Saavedra J, Corle D. Carcinoma of the gallbladder. Histologic types, stage of disease, grade, and survival rates. Cancer 1992;70:1493-7.
2. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-57.
3. Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980;68:251-306.
4. Kerr JFR, Winterford CM, Harmon BV. Apoptosis: its significance in cancer and cancer therapy. Cancer 1994;73:2013-26.
5. Trosko JE, Goodman JI. Intercellular communication may facilitate apoptosis: implications for tumor promotion. Mol Carcinog 1994;11:8-12.
6. Bates RC, Buret A, van-Helden DF, Horton MA, Burns GF. Apoptosis induced by inhibition of intercellular contact. J Cell Biol 1994;125:403-15.
7. Maeda S, Kimura H, Koga N, Lin KH, Saito T. Cell density-dependent DNA fragmentation and its suppression by heparin in primary culture of adult rat hepatocytes. Biochem Biophys Res Commun 1993;195:270-5.
8. Mathieu C, Jozan S, Mazars P, Come MG, Moisand A, Valette A. Density-dependent induction of apoptosis by transforming growth factor-beta 1 in a human ovarian carcinoma cell line. Exp Cell Res 1995;216:13-20.
9. Fujita N, Kataoka S, Naito M, Heike Y, Boku N, Nakajima M, et al. Suppression of T-lymphoma cell apoptosis by monoclonal antibodies raised against cell surface adhesion molecules. Cancer Res 1993;53:5022-7.
10. Genaro AM, Gonzalo JA, Bosca L, Martinez C. CD2-CD48 interaction prevents apoptosis in murine B lymphocytes by up-regulating Bcl-2 expression. Eur J Immunol 1994; 24:2515-21.
11. Sumimoto S, Heike T, Kanazashi S, Shintaku N, lung EY, Hata D, et al. Involvement of LFA-1/intracellular adhesion molecule-1-dependent cell adhesion in CD40-mediated inhibition of human B lymphoma cell death induced by surface IgM crosslinking. J Immunol 1994;153:2488-96.
12. Melino G, Annicchiarico-Petruzzelli M, Piredda L, Candi EI, Gentile V, Davies PJ, et al. Tissue transglutaminase and apoptosis: sense and antisense transfection studies with human neuroblastoma cells. Mol Cell Biol 1994;14:6584-96.
13. Dransfield I, Stocks SC, Haslett C, Regulation of cell adhesion molecule expression and function associated with neutrophil apoptosis. Blood 1995;85:3264-73.
14. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990;348:334-6.
15. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 1991; 352:345-7.
16. Chang F, Syrjanen S, Tervahauta A, Syrjanen K. Tumourigenesis associated with the p53 tumour suppressor gene. Br J Cancer 1993;68:653-61.
17. Teh M, Wee A, Raju GC. An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile duct/ ampullary carcinomas. Cancer 1994;74:1542-5.
18. Kamel D, Pääkkö P, Nuorva K, Vähäkangas K, Soini Y. P53 and c-erbB-2 protein expression in adenocarcinomas and epithelial dysplasias of the gall bladder. J Pathol 1993; 170:67-72.
19. Takagi S, Naito E, Yamanouchi H, Ohtsuka H, Kominami R, Yamamoto M. Mutation of the p53 gene in gallbladder cancer. Tohoku J Exp Med 1994;172:283-9.
20. Sinicrope FA, Ruan SB, Cleary KR, Stephens LC, Lee JJ, Levin B. Bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 1995;55:237-41.
21. Bosari S, Moneghini L, Graziani D, Lee AK, Murray JJ, Coggi G, et al. Bcl-2 oncoprotein in colorectal hyperplastic polyps, adenomas, and adenocarcinomas. Hum Pathol 1995; 26:534-40.
22. Fontanini G, Vignati S, Bigini D, Mussi A, Lucchi M, Angeletti CA, et al. Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer. Br J Cancer 1995;71:1003-7.
23. Joensuu H, Pylkkanen L, Toikkanen S. Bcl-2 protein expression and long-term survival in breast cancer. Am J Pathol 1994;145:1191-8.
24. Silvestrini R, Veneroni S, Daidone MG, Benini E, Boracchi P, Mezzetti M, et al. The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients. J Natl Cancer Inst 1994;86:499-504.
25. Doglioni C, Dei-Tos AP, Laurino L, Chiarelli C, Barbareschi M, Viale G. The prevalence of Bcl-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status. Virchows Arch 1994;424:47-51.
26. Gorczyca W, Markiewski M, Kram A, Tuziak T, Domagala W. Immunohistochemical analysis of Bcl-2 and p53 expression in breast carcinomas: their correlation with Ki-67 growth fraction. Virchows Arch 1995;426:229-33.
27. Pezzella F, Morrison H, Jones M, Gatter KC, Lane D, Harris AL, et al. Immunohistochemical detection of p53 and Bcl-2 proteins in non-Hodgkin's lymphoma. Histopathology 1993;22:39-44.
28. Kuwashima Y, Uehara T, Kishi K, Shiromizu K, Matsuzawa M, Takayama S. Proliferative and apoptotic status in endo-metrial adenocarcinoma. Int J Gynecol Pathol 1995;14:45-9.
29. Jussila T, Stenback F. Cell proliferation markers and growth factors in ovarian cancer. Ann Med 1995;27:87-94.
30. Lipponen P, Aaltomaa S, Kosma VM, Syrjanen K. Apoptosis in breast cancer as related to histopathological characteristics and prognosis. Eur J Cancer 1994;30A:2068-73.
31. Aihara M, Scardino PT, Truong LD, Wheeler TM, Goad JR, Yang G, et al. The frequency of apoptosis correlates with the prognosis of Gleason grade 3 adenocarcinoma of the prostate. Cancer 1995;75:522-9.
32. Vesalainen S, Lipponen P, Talja M, Syrjanen K. Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma. Eur J Cancer 1994;30A:1797-803.
33. Lipponen PK, Aaltomaa S. Apoptosis in bladder cancer as related to standard prognostic factors and prognosis. J Pathol 1994;173:333-9.
34. Gumbiner B, Stevenson B, Grimaldi A. The role of the cell adhesion molecule uvomorulin in the formation and maintenance of the epithelial junctional complex. J Cell Biol 1988;107:1575-87.
35. Albores-Saavedra J, Henson DE, Sobin LH. WHO histological classification of tumors of the gallbladder and extrahepatic bile ducts. Berlin:Springer-Verlag, 1991.
36. Hermanek P, Sobin LH, editors. UICC TNM Classification of malignant tumors. 4th edition. Tokyo: Kanehara & Co. Ltd., 1990.
37. Japanese Society of Biliary Surgery. General rules for surgical and pathological studies on cancer of biliary tract. 3rd edition. Tokyo: Kanehara & Co. Ltd., 1993.
38. Gavrieli Y, Shermen Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
39. Jankowski JA, Newham PM, Kandemir O, Hirano S, Takeichi M, Pignatelli M. Differential expression of E-cadherin in normal, metaplastic and dysplastic oesophageal mucosa: a putative biomarker. Int J Oncol 1994;4:441-8.
40. Rasbridge SA, Gillett CE, Sampson SA, Walsh FS, Millis RR. Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma. J Pathol 1993;169:245-50.
41. Campani D, Cecchetti D, Bevilacqua G. Immunocytochemical p53 detection by microwave oven heating of routinely-fixed paraffin section. J Pathol 1993;171:151-2.
42. Bursch W, Paffe S, Putz B, Barthel G, Schulte-Hermann R. Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats. Carcinogenesis 1990;11:847-53.
43. Craig RW. The bcl-2 gene family. Semin Cancer Biol 1995;6:35-43.
44. Krajewska M, Moss SF, Krajewski S, Song K, Holt PR, Reed JC. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas. Cancer Res 1996;56:2422-7.
45. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993;74:609-19.
46. Levine AJ, Momand J, Finlay CA. The p53 tumor suppressor gene. Nature 1991;351:453-6.
47. Purdie CA, O'Grady J, Piris J, Wyllie AH, Bird CC. p53 expression in colorectal tumors. Am J Pathol 1991;138:807-13.
48. Symmans WF, Katz RL, Ordonez NG, Dalton H, Romaguera JE, Cabanillas F. Transformation of follicular lymphoma. Expression of p53 and bcl-2 oncoprotein, apoptosis and cell proliferation Acta Cytol 1995;39:673-82.